. "9 Haemophilus influenzae Type b Vaccines ." Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Casuality. Washington, DC: The National Academies Press, 1994.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality
Todd JK, Bruhn FW. Severe Haemophilus influenzae infections: spectrum of disease. American Journal of Diseases in Children 1975;129:607-611.
Topley WW. The role of active or passive immunization in the control of enteric infection. Lancet 1938;1:181-186.
Trollfors B, Lagergard T, Claesson BA, Thomberg E, Martinell J, Schneerson R. Characterization of the serum antibody response to the capsular polysaccharide Haemophilus influenzae type b in children with invasive infections. Journal of Infectious Disease 1992;166:1335-1339.
Tudor-Williams G, Frankland J, Isaacs D, Mayon-White RT, MacFarlane JA, Rees DG, et al. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Archives of Disease in Childhood 1989;64:520-524.
Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign (letter). Lancet 1989;2:440-441.
Vadheim CM. Reduction of Hib disease in Southern California, 1983-1991. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 1726, p. 398. Washington, DC: American Society for Microbiology; 1992.
Vadheim CM, Greenberg DP, Marcy SM, Froeschle J, Ward JI. Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children. Pediatric Infectious Disease Journal 1990;9:555-561.
Walter EB. Moggio MV, Drucker RP, Wilfert CM. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. Pediatric Infectious Disease Journal 1990:9:632-635.
Ward J, Cochi S. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders; 1988.
Watemberg N, Dagan R, Arbelli Y, Belmaker I, Morag A, Hessel L, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatric Infectious Disease Journal 1991;10:758-763.
Weinberg GA, Granoff DM. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. Journal of Pediatrics 1988;113:621-631.
Weinberg GA, Granoff DM. Immunogenicity of Haemophilus influenzae type polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine. Pediatrics 1990;85(4 Pt 2):654-661.
Weinberg GA, Einhorn MS, Lenois AA, Granoff PD, Granoff DM. Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Journal of Pediatrics 1987;111:22-27.
Weisman SJ, Cates KL, Allegretta GJ, Quinn JJ, Altman AJ. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer. Journal of Pediatrics 1987:111:727-729.
Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Pediatrics 1990;85(4 Pt 2):690-693.